Journal Title：Critical Reviews In Immunology

Immunology covers a broad spectrum of investigations at the genes, molecular, cellular, organ and system levels to reveal defense mechanisms against pathogens as well as protection against tumors and autoimmune diseases. The great advances in immunology in recent years make this field one of the most dynamic and rapidly growing in medical sciences. Critical ReviewsTM in Immunology (CRI) seeks to present a balanced overview of contemporary adaptive and innate immune responses related to autoimmunity, tumor, microbe, transplantation, neuroimmunology, immune regulation and immunotherapy from basic to translational aspects in health and disease. The articles that appear in CRI are mostly obtained by invitations to active investigators. But the journal will also consider proposals from the scientific community. Interested investigators should send their inquiries to the editor before submitting a manuscript.

免疫學涵蓋了基因、分子、細胞、器官和系統(tǒng)層面的廣泛研究，旨在揭示針對病原體的防御機制以及對腫瘤和自身免疫性疾病的保護。近年來，免疫學取得了巨大進步，使該領(lǐng)域成為醫(yī)學科學中最具活力和發(fā)展最快的領(lǐng)域之一。《免疫學評論》 (CRI) 旨在從健康和疾病的基礎(chǔ)到轉(zhuǎn)化方面，對與自身免疫、腫瘤、微生物、移植、神經(jīng)免疫學、免疫調(diào)節(jié)和免疫治療相關(guān)的當代適應(yīng)性和先天性免疫反應(yīng)進行平衡概述。CRI 上刊登的文章大多是通過邀請活躍的研究人員獲得的。但該雜志也會考慮來自科學界的提案。感興趣的研究人員應(yīng)在提交稿件之前向編輯發(fā)送詢問。

Critical Reviews In Immunology創(chuàng)刊于1980年，由Begell House Inc.出版商出版，收稿方向涵蓋醫(yī)學 - 免疫學全領(lǐng)域，此期刊水平偏中等偏靠后，在所屬細分領(lǐng)域中專業(yè)影響力一般，過審相對較易，如果您文章質(zhì)量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 12周，或約稿 ，影響因子指數(shù)0.8，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學者值得一試。